Results for tag: "Nafamostat"

Nafamostat is a hematological drug used to treat a variety of conditions, including disseminated intravascular coagulation (DIC), thrombosis, and sepsis. It is a direct thrombin inhibitor, meaning it works by blocking the action of thrombin, an enzyme involved in the clotting process. Nafamostat is also used to prevent bleeding during surgery and to treat acute pancreatitis. Nafamostat is available in both injectable and oral forms, and is used in a variety of settings, including hospitals, clinics, and home care. It is also used in combination with other drugs to treat a variety of conditions. The nafamostat market is highly competitive, with a number of companies offering products. Some of the major players in the market include Daiichi Sankyo, Pfizer, Sanofi, Merck, and Bristol-Myers Squibb. Show Less Read more